Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
Veröffentlicht: 20.03.2026 um 03:00 Uhr, prnewswire.co.uk
en | boerse | 68922071 |
